Currently takes no b12 supplements
While WHO has been looking into reports about falsified semaglutide medications in multiple regions since 2022, this is the first time the organization has issued an official warning
Among women with class I obesity (BMI 30.034.9 kg/m), miscarriage occurred in 4.0% of semaglutide users versus 5.4% of controls (OR 0.73, 95% CI 0.351.55, p = 0.41)
If you reconstitute with the wrong volume of water, your concentration will be different from what you expect, and every subsequent dose will be wrong
Researchers observed that weight loss with semaglutide ranged from 9.6 to 17.1% in participants without gastrointestinal AEs and from 11.4 to 17.7% in those with gastrointestinal AEs, suggesting gastrointestinal AEs appeared to contribute little to the weight-loss benefit of semaglutide, which were consistent with previous studies that the weight-loss effects of semaglutide in patients with obesity and/or T2DM indicated little contribution of gastrointestinal AEs ( Clinical prioritization of the disproportionality signals In this study, we innovatively used a rating scale to further analyze the disproportionality signals in order to prioritize safety signals and avoid unnecessary warnings